• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant human Vesicular, overexpressed in cancer, prosurvival protein 1 protein

ACP20442

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP20442 Target NameVOPP1
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range23-172aaMol Weight44.2kD
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ96AW1
Background Information
  • Uniprot Id

    Q96AW1

  • Target Species

    Human

  • Target Name

    VOPP1

  • Target Full Name

    WW domain binding protein VOPP1

  • Target Function

    Increases the transcriptional activity of NFKB1 by facilitating its nuclear translocation, DNA-binding and associated apoptotic response, when overexpressed.

  • Target Subcellular Location

    Cytoplasmic vesicle membrane; Single-pass type I membrane protein. Note=When overexpressed, localizes in the nucleus and perinuclear regions.

  • Target Protein Families

    VOPP1/ECOP family

  • Target Tissue Specificity

    Widely expressed with highest levels in thymus and ovary.

  • Target Research Area

    Epigenetics and Nuclear Signaling

  • Target Synonyms

    VOPP1; ECOP; GASP; Vesicular; overexpressed in cancer; prosurvival protein 1; EGFR-coamplified and overexpressed protein; ECop; Glioblastoma-amplified secreted protein; Putative NF-kappa-B-activating protein 055N

Inquire Recombinant human Vesicular, overexpressed in cancer, prosurvival protein 1 protein Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification